Phio Pharmaceuticals Corp.
PHIO· Nasdaq
Released May 11, 2023, after the close
10-Q filed May 11, 2023, 41 days after period end · 0001683168-23-003213
| Metric | Q1 2023 | Q1 2022 | Q1 2021 | Q1 2020 |
|---|---|---|---|---|
| Revenue | — | — | — | $0.00 |
| Net Income | -$3.60M | -$2.64M | -$3.41M | -$2.35M |
| EPS Diluted |
Phio Pharmaceuticals Corp. · CIK 1533040 · Engraved from SEC EDGAR
| -$3.15 |
| -$2.34 |
| -$0.32 |
| -$1.33 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.